UPDATE : Monday, September 7, 2020
상단여백
MSD Korea’s trade union refuses to use controversial monitoring program by Kim Yun-mi 2020-06-11 14:31
MSD Korea’s privacy breach controversy resurfaces by Kim Yun-mi 2020-06-09 11:26
Drug sales reps move briskly amid worries over Covid-19 resurge by Kim Yun-mi 2020-06-08 15:52
Rinvoq joins competition among JAK inhibitors by Kim Yun-mi 2020-06-05 16:16
‘Alecensa beat crizotinib as treatment of ALK-positive NSCLC’ by Kim Yun-mi 2020-06-05 14:53
라인
Seoul OKs special import of remdesivir as Covid-19 treatment by Kim Yun-mi 2020-06-03 16:05
‘KOEDC to broaden drug accessibility for patients with rare diseases’ by Kim Yun-mi 2020-06-03 12:37
‘Keytruda doubled survival in advanced colon cancer compared to chemo’ by Kim Yun-mi 2020-06-02 11:27
Psychiatric nurse prevents patient violence with quick judgment by Kim Yun-mi 2020-05-29 17:00
Heathcare experts shun online meetings: survey by Kim Yun-mi 2020-05-29 16:55
라인
Kisqali offers survival benefit to breast cancer patients with visceral metastases by Kim Yun-mi 2020-05-29 10:58
[News Focus] Remdesivir alone not enough to kill Covid-19 by Kim Yun-mi 2020-05-27 14:20
Regulator suspends sales of 31 diabetes drugs citing possible carcinogen by Kim Yun-mi 2020-05-26 14:50
Korean pharma’s Q1 performance not affected by Covid-19 by Kim Yun-mi 2020-05-22 17:29
‘No reckless interpretations of Moderna’s Covid-19 vaccine results’   by Kim Yun-mi 2020-05-22 15:27
라인
Cancer patients demand Ono, BMS, MSD share immunotherapy cost by Kim Yun-mi 2020-05-15 15:56
Regulator detects illegal substances in directly purchased health food by Kim Yun-mi 2020-05-14 16:05
‘Lynparza extended survival of ovarian cancer patients’ by Kim Yun-mi 2020-05-14 15:14
AZ, Takeda use different strategies on ovarian cancer by Kim Yun-mi 2020-05-13 12:34
Metformin sparks heated discussions among diabetes experts  by Kim Yun-mi 2020-05-12 15:21
여백
여백
여백
Back to Top